Abstract |
This study evaluated the effects of long-chain bases from sea cucumber (SC-LCBs) on modulation of the gut microbiota and inhibition of obesity in high fat diet-fed mice. Results showed that SC-LCBs exerted significant antiobese effects, which were associated with the inhibition of hyperglycemia and lipid accumulation. SC-LCBs also regulated serum adipocytokines toward to normal levels. SC-LCBs caused significant decreases in Firmicutes, Actinobacteria phylum, and obesity-related bacteria (Desulfovibro, Bifidobacterium, Romboutsia etc. genus). SC-LCBs also elevated Bacteroidetes, Proteobacteria, Verrucomicrobia phylum, and short chain fatty acids (SCFAs)-producing bacteria (Bacteroides, Lactobacillus, Lachnospiraceae_NK4A136_group etc. genus). Moreover, serum and fecal lipoplysaccharide (LPS) concentrations and its dependent toll-line receptor 4 pathway were inhibited by SC-LCBs treatment. SC-LCBs caused increases in fecal SCFAs and their mediated G-protein-coupled receptors proteins. These suggest that SC-LCBs alleviate obesity by altering gut microbiota. Thus, it sought to indicate that SC-LCBs can be developed as food supplement for the obesity control and the human gut health.
|
Authors | Shiwei Hu, Yangli Xu, Xiang Gao, Shijie Li, Wei Jiang, Yu Liu, Laijin Su, Huicheng Yang |
Journal | Marine drugs
(Mar Drugs)
Vol. 17
Issue 8
(Aug 01 2019)
ISSN: 1660-3397 [Electronic] Switzerland |
PMID | 31374958
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Bacteria
(drug effects, isolation & purification, metabolism)
- Diet, High-Fat
(adverse effects)
- Dietary Supplements
- Disease Models, Animal
- Feces
(microbiology)
- Gastrointestinal Microbiome
(drug effects)
- Glycosphingolipids
(administration & dosage, isolation & purification)
- Humans
- Intestinal Mucosa
(microbiology)
- Male
- Mice
- Obesity
(diet therapy, etiology, microbiology)
- Sea Cucumbers
(chemistry)
|